BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21123444)

  • 1. A new small-molecule antagonist inhibits Graves' disease antibody activation of the TSH receptor.
    Neumann S; Eliseeva E; McCoy JG; Napolitano G; Giuliani C; Monaco F; Huang W; Gershengorn MC
    J Clin Endocrinol Metab; 2011 Feb; 96(2):548-54. PubMed ID: 21123444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A drug-like antagonist inhibits thyrotropin receptor-mediated stimulation of cAMP production in Graves' orbital fibroblasts.
    Neumann S; Pope A; Geras-Raaka E; Raaka BM; Bahn RS; Gershengorn MC
    Thyroid; 2012 Aug; 22(8):839-43. PubMed ID: 22784331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A small molecule antagonist inhibits thyrotropin receptor antibody-induced orbital fibroblast functions involved in the pathogenesis of Graves ophthalmopathy.
    Turcu AF; Kumar S; Neumann S; Coenen M; Iyer S; Chiriboga P; Gershengorn MC; Bahn RS
    J Clin Endocrinol Metab; 2013 May; 98(5):2153-9. PubMed ID: 23482611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotropin, but Not Thyroid-Stimulating Antibodies, Induces Biphasic Regulation of Gene Expression in Human Thyrocytes.
    Jang D; Morgan SJ; Klubo-Gwiezdzinska J; Banga JP; Neumann S; Gershengorn MC
    Thyroid; 2020 Feb; 30(2):270-276. PubMed ID: 31805824
    [No Abstract]   [Full Text] [Related]  

  • 5. Small molecule TSHR agonists and antagonists.
    Neumann S; Gershengorn MC
    Ann Endocrinol (Paris); 2011 Apr; 72(2):74-6. PubMed ID: 21511239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of thyrotropin-receptor blocking antibodies on stimulating autoantibodies from patients with Graves' disease.
    Lenzner C; Morgenthaler NG
    Thyroid; 2003 Dec; 13(12):1153-61. PubMed ID: 14751037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TSH receptor antibodies do not alter the function of gonadotropin receptors stably expressed in eukaryotic cells.
    Tonacchera M; Ferrarini E; Dimida A; Agretti P; De Marco G; De Servi M; Chiovato L; Cetani F; Vitti P; Pinchera A
    Eur J Endocrinol; 2004 Mar; 150(3):381-7. PubMed ID: 15012625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
    Neumann S; Huang W; Eliseeva E; Titus S; Thomas CJ; Gershengorn MC
    Endocrinology; 2010 Jul; 151(7):3454-9. PubMed ID: 20427476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutral antibodies to the TSH receptor are present in Graves' disease and regulate selective signaling cascades.
    Morshed SA; Ando T; Latif R; Davies TF
    Endocrinology; 2010 Nov; 151(11):5537-49. PubMed ID: 20844004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-molecule agonists for the thyrotropin receptor stimulate thyroid function in human thyrocytes and mice.
    Neumann S; Huang W; Titus S; Krause G; Kleinau G; Alberobello AT; Zheng W; Southall NT; Inglese J; Austin CP; Celi FS; Gavrilova O; Thomas CJ; Raaka BM; Gershengorn MC
    Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12471-6. PubMed ID: 19592511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graves' Autoantibodies Exhibit Different Stimulating Activities in Cultures of Thyrocytes and Orbital Fibroblasts Not Reflected by Clinical Assays.
    Krieger CC; Kahaly GJ; Azam A; Klubo-Gwiezdzinska J; Neumann S; Gershengorn MC
    Thyroid; 2022 Jan; 32(1):90-96. PubMed ID: 34714162
    [No Abstract]   [Full Text] [Related]  

  • 12. Stimulatory TSH-Receptor Antibodies and Oxidative Stress in Graves Disease.
    Diana T; Daiber A; Oelze M; Neumann S; Olivo PD; Kanitz M; Stamm P; Kahaly GJ
    J Clin Endocrinol Metab; 2018 Oct; 103(10):3668-3677. PubMed ID: 30099546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
    Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
    Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Mouse Thyrotropin Receptor A-Subunit Transgene Expressed in Thyroiditis-Prone Mice May Provide Insight into Why Graves' Disease Only Occurs in Humans.
    McLachlan SM; Aliesky HA; Rapoport B
    Thyroid; 2019 Aug; 29(8):1138-1146. PubMed ID: 31184281
    [No Abstract]   [Full Text] [Related]  

  • 15. Exosomes Expressing Thyrotropin Receptor Attenuate Autoantibody-Mediated Stimulation of Cyclic Adenosine Monophosphate Production.
    Edo N; Kawakami K; Fujita Y; Morita K; Uno K; Tsukamoto K; Onose H; Ishikawa T; Ito M
    Thyroid; 2019 Jul; 29(7):1012-1017. PubMed ID: 31062662
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of nonionic polymers on thyroid stimulation and TSH receptor binding by the human monoclonal TSH receptor autoantibody M22.
    Ochi Y; Hamazu M; Kajita Y; Hachiya T; Miyata T; Barrett C; Smith BR
    Thyroid; 2009 Jan; 19(1):47-52. PubMed ID: 18976151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyrotropin receptor-stimulating Graves' disease immunoglobulins induce hyaluronan synthesis by differentiated orbital fibroblasts from patients with Graves' ophthalmopathy not only via cyclic adenosine monophosphate signaling pathways.
    van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
    Thyroid; 2011 Feb; 21(2):169-76. PubMed ID: 20954819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A selective TSH receptor antagonist inhibits stimulation of thyroid function in female mice.
    Neumann S; Nir EA; Eliseeva E; Huang W; Marugan J; Xiao J; Dulcey AE; Gershengorn MC
    Endocrinology; 2014 Jan; 155(1):310-4. PubMed ID: 24169564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease.
    Tsui S; Naik V; Hoa N; Hwang CJ; Afifiyan NF; Sinha Hikim A; Gianoukakis AG; Douglas RS; Smith TJ
    J Immunol; 2008 Sep; 181(6):4397-405. PubMed ID: 18768899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in TSH receptor binding and thyroid-stimulating properties between TSH and Graves' IgG. Slowly-acting TSH receptor antibody moieties in Graves' sera affect assay data.
    Saiki Y; Ishihara T; Ikekubo K; Mori T
    Endocr J; 2005 Feb; 52(1):45-55. PubMed ID: 15758557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.